Metastatic Carcinoma in the Liver
8 clinical trials · Condition
◉ Watch Metastatic Carcinoma in the Liver
| Record | Firm | Date |
|---|---|---|
| BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers (NCT04021043) | M.D. Anderson Cancer Center | 2019-08-19 |
| Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT03403634) | Roswell Park Cancer Institute | 2018-04-19 |
| Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver (NCT03005002) | City of Hope Medical Center | 2017-06-28 |
| Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery (NCT02754856) | M.D. Anderson Cancer Center | 2016-08-29 |
| PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer (NCT02837263) | University of Wisconsin, Madison | 2016-08-11 |
Track Metastatic Carcinoma in the Liver automatically
Every clearance here is in the API, with alerts when new ones post.